A company set up by two Scottish rugby internationals to provide an alternative to mainstream painkillers has secured its first external investor after reporting a surge in sales due to “covanxiety”.
After more than a year of delays due to logistical errors and allegations of impropriety, the state has picked 11 companies to expand and diversify Maryland’s medical cannabis industry.
A Sarnia-Lambton doctor who has been researching cannabis as a treatment for dementia says he wants to see cannabinoid therapy for people with the disease covered by public health insurance.